DrugPatentWatch Database Preview

Wockhardt Company Profile

« Back to Dashboard

What is the competitive landscape for WOCKHARDT, and what generic and branded alternatives to WOCKHARDT drugs are available?

WOCKHARDT has one hundred and sixty-nine approved drugs.

There are five tentative approvals on WOCKHARDT drugs.

Summary for Wockhardt

US Patents:	0
Tradenames:	131
Ingredients:	121
NDAs:	169
Patent Litigation for Wockhardt:	See patent lawsuits for Wockhardt
PTAB Cases with Wockhardt as petitioner:	See PTAB cases with Wockhardt as petitioner

Drugs and US Patents for Wockhardt

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wockhardt Ltd	FEXOFENADINE HYDROCHLORIDE HIVES	fexofenadine hydrochloride	TABLET;ORAL	079112-003	Feb 8, 2012		OTC	No	No
Wockhardt	RISPERIDONE	risperidone	TABLET;ORAL	078871-002	Oct 9, 2008	AB	RX	No	No
Wockhardt	RISPERIDONE	risperidone	TABLET;ORAL	078871-005	Oct 9, 2008	AB	RX	No	No
Wockhardt Usa	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	202176-001	Sep 14, 2012	AB	RX	No	No
Wockhardt Ltd	MEMANTINE HYDROCHLORIDE	memantine hydrochloride	TABLET;ORAL	090073-002	Sep 4, 2015	AB	RX	No	No
Wockhardt	RISPERIDONE	risperidone	TABLET;ORAL	078871-001	Oct 9, 2008	AB	RX	No	No
Wockhardt	DIVALPROEX SODIUM	divalproex sodium	TABLET, DELAYED RELEASE;ORAL	077296-002	Jul 31, 2008	AB	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Wockhardt
• Wockhardt Bio Ag
• Wockhardt Eu Operatn
• Wockhardt Ltd
• Wockhardt Usa